Skip to main content

From the Helm: CSL’s David Lamont on the biotech giant’s bright future

Jessica Amir
February 20, 2020

In the latest instalment of Bell Direct’s From the Helm series, Jess has a chat with CSL’s CFO David Lamont.

David gives the inside scoop on CSL, the market leader in the blood plasma and vaccine market. Additionally, he explains CSL’s own products, programmes and partnerships, and the steps taken by the medical giant to tackle coronavirus.

Plus, he sheds some light on the unique situation the broader pharmaceuticals industry finds itself in when it comes to new competition, as well as CSL’s future proofing strategy.

Morning Bell 20 May

Bell Direct
May 20, 2025

Morning Bell 19 May

Grady Wulff
May 19, 2025

Weekly Wrap 16 May

Bell Direct
May 16, 2025

Morning Bell 15 May

Bell Direct
May 15, 2025

Morning Bell 14 May

Bell Direct
May 14, 2025

Morning Bell 13 May

Grady Wulff
May 13, 2025

Morning Bell 12 May

Bell Direct
May 12, 2025

Weekly Wrap 9 May

Bell Direct
May 9, 2025

Morning Bell 8 May

Sophia Mavridis
May 8, 2025

Morning Bell 7 May

Bell Direct
May 7, 2025

Morning Bell 6 May

Grady Wulff
May 6, 2025